Report : Asia Pacific Medical Tubing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Material [Polyvinyl Chloride (PVC), Polyimide/Nylons, PTFE/Thermoplastic Elastomers (TPES), Thermoplastic Polyurethanes (TPUS), Polyvinylidene Fluoride (PVDF), Polypropylene and Polyethylene, Silicon, and Others], Structure (Single-Lumen, Multi-Lumen, Multi-Layer Extruded Tubing, Tapered or Bump Tubing, Braided Tubing, Balloon Tubing, Corrugated Tubing, Heat Shrink Tubing, and Others), Application (Bulk Disposable Tubing, Catheter & Cannula, Drug Delivery System, and Others), and End User (Hospitals and Clinics, Ambulatory Care Centres, Medical Device Companies, Laboratories, and Others)
At 7.5% CAGR, the Asia Pacific Medical Tubing Market is speculated to be worth US$ 4,753.46 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Asia Pacific medical tubing market was valued at US$ 3,072.12 million in 2022 and is expected to reach US$ 4,753.46 million by 2028, registering a CAGR of 7.5% from 2022 to 2028. Increase in number of patients requiring tube feeding and rise in minimally invasive surgical procedures are the critical factors attributed to the Asia Pacific medical tubing market expansion.
A feeding tube is used to provide nutrients to patients who don’t get enough nutrition from ingested food. A medical tube is inserted in the stomach or small intestine to deliver liquid nutrition directly. Tube feeding procedure is prescribed to patients with gastrointestinal dysfunction, head and neck cancer (which make swallowing difficult), neurological disorders (including stroke and paralysis), and other medical conditions. Crohn’s disease, a gastrointestinal disease associated with trauma, bowel obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative colitis are a few gastrointestinal disorders. Therefore, a surge in the number of patients suffering from gastrointestinal dysfunction, head and neck cancer (which make swallowing difficult), and neurological disorders (including stroke and paralysis) boosts the demand for tube feeding, thus driving the Asia Pacific medical tubing market growth.
On the contrary, complications associated with medical tubes hampers the Asia Pacific medical tubing market.
Based on material, the Asia Pacific medical tubing market is segmented into polyvinyl chloride (PVC), polyimide/nylons, PTFE/thermoplastic elastomers (TPES), thermoplastic polyurethanes (TPUS), polyvinylidene fluoride (PVDF), polypropylene and polyethylene, silicon, others. The polyvinyl chloride (PVC) segment held 31.3% share of Asia Pacific medical tubing market in 2022, amassing US$ 962.52 million. It is projected to garner US$ 1,476.05 million by 2028 to expand at 7.4% CAGR during 2022–2028.
Based on structure, the Asia Pacific medical tubing market is segmented into single-lumen, multi-lumen, multi-layer extruded tubing, tapered or bump tubing, braided tubing, balloon tubing, corrugated tubing, heat shrink tubing, and others. The single-lumen segment held 19.8% share of Asia Pacific medical tubing market in 2022, amassing US$ 607.47 million. It is projected to garner US$ 961.11 million by 2028 to expand at 7.9% CAGR during 2022–2028.
Based on application, the Asia Pacific medical tubing market is segmented into bulk disposable tubing, catheter & cannula, drug delivery system, and others. The bulk disposable tubing segment held 34.0% share of Asia Pacific medical tubing market in 2022, amassing US$ 1,044.50 million. It is projected to garner US$ 1,627.42 million by 2028 to expand at 7.7% CAGR during 2022–2028.
Based on end user, the Asia Pacific medical tubing market is segmented into hospitals and clinics, ambulatory care centres, medical device companies, laboratories, and others. The hospitals and clinics segment held 61.1% share of Asia Pacific medical tubing market in 2022, amassing US$ 1,878.40 million. It is projected to garner US$ 2,888.08 million by 2028 to expand at 7.4% CAGR during 2022–2028.
Based on country, the Asia Pacific medical tubing market has been categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 31.7% share of Asia Pacific medical tubing market in 2022. It was assessed at US$ 973.59 million in 2022 and is likely to hit US$ 1,499.69 million by 2028, exhibiting a CAGR of 7.5% during the forecast period.
Key players dominating the Asia Pacific medical tubing market are Compagnie de Saint Gobain SA; Nordson Corp; Optinova AB; Spectrum Plastics Group Inc; TE Connectivity Ltd; and Trelleborg AB, among others.
- In June 2020; Nordson Corporation acquired Fluortek, Inc., an Easton, Pennsylvania-based precision plastic extrusion manufacturer that provides custom-dimensioned tubing to the medical device industry. The acquisition of Fluortek is expected to enhance the company's ability to deliver critical components. This offering further supports Nordson MEDICAL’s position as a leading full-service solution provider of component and device manufacturing capabilities for OEMs across the interventional, minimally invasive, and surgical medical device landscape.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com